When: Q3 earnings beat-and-raise with revenue >$5.4B, gross margin >60%, and buyback re-acceleration above $100M

Then: Full re-engagement with structural confirmation

HOLD

• Price at 260.05 is below every major moving average: 10 EMA (268), 50 SMA (287), Bollinger middle (274), VWMA (274), and 200 SMA (233.44)
• MACD at negative 6.41 with signal at negative 4.98 and histogram widening to negative 1.44; RSI at 37.40 with lower highs on every bounce and zero bullish divergence
• Five consecutive lower closes with distribution volume profile indicating institutional sellers actively in control
• Entry at 260 with stop at 230 implies roughly 11.5% drawdown; if 200 SMA fails, no major support until 2025 lows around 155—a regime change, not just a technical event
• Simply Wall St. fair value raised to 324.45, but gross math gives ~2.2-to-1 risk-reward, not 3-to-1 as aggressive analyst claims; DCF model outputs are not price targets
• Trailing P/E of 39.5x; forward P/E of 24.4x contingent on hitting $10.64 EPS, with execution risk on capacity utilization, demand recovery, and margin expansion
• Inventory at $4.8 billion is 165% of 2021 levels against ~3% revenue growth since then; inventory represents 27% of revenue with $240 million gross profit hit at just 5% markdown
• Beta of 1.33 amplifies market moves; Polymarket pricing 86% probability of zero Fed cuts in 2026 and 66% probability of 10-year yield touching 4.8% before year-end
• ADI's 'monster quarter' and Seaport upgrade on AI data center commentary represents direct competitive threat in highest-growth subsegment; Vicor's Gen 2 VPD targets AI power density bottleneck
• Position sizing concern: Tranche 1 alone represents 60-80% of benchmark weight in a $237 billion market cap name with confirmed downtrend momentum

→ vs aggressive: The 3-to-1 risk-reward calculation is structurally flawed: fair value models are not price targets, gross math gives ~2.2-to-1, and the stop at 200 SMA is the level where the thesis is invalidated rather than a stable floor

→ vs aggressive: Dismissing technical posture as 'noise' ignores that price is below every single short and medium-term measure of value simultaneously with confirmed downtrend momentum and distribution volume

→ vs aggressive: Macro dismissal ignores that 86% probability of zero Fed cuts and 66% probability of 10-year at 4.8% represent base case, not tail risk, for a high-beta semiconductor name

→ vs aggressive: Inventory framing as 'strategic positioning' ignores TXN's own conservative guidance and the $240 million to billions in potential gross profit impact from inventory writedowns

→ vs aggressive: Competitive dismissal of ADI and Vicor as 'niche players' misses that disruption typically comes from smaller focused players, and AI power density is the exact bottleneck hyperscalers pay premiums to solve

→ vs aggressive: Waiting for confirmation is not 'waiting at the top of a compounder'—it is disciplined capital preservation that preserves optionality while technical structure resolves

HOLD

• Reduce Tranche 1 from 40% to 25% of intended position, targeting 38-50% of benchmark weight initial exposure
• Defer buy by 1-3 sessions to wait for stabilization at lower Bollinger Band ($258.34) or daily close above $262 with improving internals
• Keep stop loss at $230 (200 SMA level) given elevated ATR of 10.13; tightening to $235 offers no meaningful protection
• Add explicit position management rule: exit entire position immediately if 200 SMA fails on daily closing basis within two weeks
• Corrects aggressive analyst's 1:3 risk-reward to 2.1:1 ratio based on $260 to $324.45 (24.6% upside) versus $260 to $230 (11.5% downside)
• Fair value upgraded from $298 to $324.45; top-decile compounder at 24.4x forward P/E warrants more than a HOLD recommendation
• Q3 earnings is an upcoming binary catalyst; waiting for perfect technical confirmation risks missing the move
• Fundamentals remain compelling: 35.2% ROE, 31% net margins, IDM2.0 moat, capex inflection ($5.07B to $4.55B), FCF recovery ($1.35B to $2.60B)
• Peer underperformance versus ADI reflects post-earnings digestion and beta-driven selling, not fundamental competitive collapse
• This is a mid-cycle compounder setup with manageable near-term headwinds, not a binary setup

→ vs aggressive: The 1:3 risk-reward is materially overstated; actual ratio is 2.1:1 at best, requiring both directional accuracy and timing precision in a confirmed downtrend

→ vs aggressive: All short and medium-term indicators are bearish simultaneously (MACD widening negatively, RSI making lower highs, volume confirming distribution, price on lower Bollinger Band); characterizing this as 'noise' is disciplined by markets

→ vs conservative: HOLD recommendation underweights the fair value upgrade from $298 to $324.45 and the quality of a top-decile compounder at 24.4x forward earnings

→ vs conservative: Specified trigger conditions (close above 268 with MACD contraction or 200 SMA retest with RSI divergence) are mutually exclusive and may cause missed 15-20% moves during multi-week consolidation

→ vs conservative: Waiting for perfect technical confirmation before Q3 earnings risks buying the post-earnings squeeze rather than accumulating beforehand

→ vs conservative: Competition narrative (ADI quarter, Vicor VPD) overstates competitive threat to TXN's 100,000+ customer base and manufacturing scale